Early Access — free while we kick the tires
EdgarHawk

Higgins Stephen T.

EVP & CAO

Officer
2 filings analyzed · 1 company · Latest 2026-02-24

Companies

Company Buys Sells Direction
FREEPORT-MCMORAN INC FCX 0 2 Net selling

Activity

February 2026
2026-02-24 FREEPORT-MCMORAN INC FCX
high
Sell
29,654 shares
$1,868,202
Significance 6/10

EVP Higgins sells 29,654 FCX shares at $63.00; stock now $67.88; cross-ticker track record shows 90d well-timed rate 100.00%

Higgins sold 29,654 shares (29.7K shares) at $63.00 on 2026-02-20, reducing his holdings by 27.9% from 106,099 to 76,445 shares, for a total of $1,868,202.00 ($1.9M). The stock has since rallied to $67.88 (the 52-week high), meaning this sale was executed ahead of the most recent appreciation—specifically the 12.4% gain over the past 30 days. His cross-ticker open-market track record shows 4 prior sells with a 90-day well-timed rate of 100.00%, and 3 of his 3 prior FCX sales were well-timed at the 90-day mark, suggesting a pattern of selling before downturns rather than at local tops. The current stock price at the 52-week peak contradicts that pattern for this transaction. Investors should note whether this represents a departure from his demonstrated timing discipline or reflects near-term profit-taking at a cyclical high in a commodity-exposed producer ($7.0B revenue, $1.2B net income, P/E 23.99).

December 2025
2025-12-12 FREEPORT-MCMORAN INC FCX
high
Sell
28,423 shares
$1,363,900
Significance 6/10

EVP Higgins sold 28,423 shares of FCX at $47.99; prior 3 same-ticker sells all showed negative 90d returns (-5.4% to -21.1%).

Higgins Stephen T. (EVP & CAO) sold 28,423 shares (28.4K shares) of Freeport-McMoRan Inc on 2025-12-11 at $47.99, reducing his holdings by 21.3% to 105,294 shares. His three prior open-market sales at FCX, conducted in May 2024, all preceded declines at the 90-day horizon: -21.1%, -13.3%, and -14.2% respectively, establishing a pattern of well-timed exits. The current sale occurs near the 52-week high ($48.11), with the stock up 13.3% over 30 days and 6.0% over 90 days from prior levels. The company's fundamentals show solid underlying health (Revenue $7.0B, Net income $1.2B, Annual revenue growth +11.4%, P/E 15.79), suggesting the sale reflects portfolio management rather than distress signaling. The pattern of prior well-timed exits at this ticker warrants observation of whether this trade similarly precedes a pullback.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access